|
INHIBITS CYP3A4 AND CAN INCREASE SERUM AMIODARONE LEVELS
|
VIT B12 ABSORPTION FROM THE GUT IS EFFECTED BY THE DRUG
|
VIT B12 ABSORPTION FROM THE GUT IS EFFECTED BY THE DRUG
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CO-ADMINISTRATION LEADS TO AN INCREASE OF ABOUT 18% IN AUC OF LOSARTAN WITH NO EFFECT ON PHARMACOKINETICS OF ITS ACTIVE METABOLITES
|
THEOPHYLLIN PLASMA CONCENTRATION IS RAISED BY THE DRUG
|
THEOPHYLLIN PLASMA CONCENTRATION IS RAISED BY THE DRUG
|
THEOPHYLLIN PLASMA CONCENTRATION IS RAISED BY THE DRUG
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
CISAPRIDE ENHANCES THE GASTRIC ABSORPTION OF CIMETIDINE & RANITIDINE WHILE THERE IS INCREASED PEAK PLASMA CONCENTRATION & AUC OF CISAPRIDE ASWELL BECAUSE OF CIMETIDINE AND RANITIDINE CO-ADMINISTRATION
|
CISAPRIDE ENHANCES THE GASTRIC ABSORPTION OF CIMETIDINE & RANITIDINE WHILE THERE IS INCREASED PEAK PLASMA CONCENTRATION & AUC OF CISAPRIDE ASWELL BECAUSE OF CIMETIDINE AND RANITIDINE CO-ADMINISTRATION
|
CO-ADMINISTRATION WITH ORAL CIMETIDINE MAY INCREASE PEAK METFORMIN PLASMA AND WHOLE BLOOD CONCENTRATIONS BY 60% AND 40%
|
CO-ADMINISTRATION WITH ORAL CIMETIDINE MAY INCREASE PEAK METFORMIN PLASMA AND WHOLE BLOOD CONCENTRATIONS BY 60% AND 40%
|
CIMETIDINE DECREASES THE BIOAVAILABILITY OF THE DRUG, MAY BE DUE TO INCREASED GASTRIC PH LEADING TO REDUCED ABSORPTION
|
CIMETIDINE DECREASES THE BIOAVAILABILITY OF THE DRUG, MAY BE DUE TO INCREASED GASTRIC PH LEADING TO REDUCED ABSORPTION
|
CIMETIDINE DECREASES THE BIOAVAILABILITY OF THE DRUG, MAY BE DUE TO INCREASED GASTRIC PH LEADING TO REDUCED ABSORPTION
|
CYTOCHROME P450 INHIBITORS MAY INHIBIT 25 HYDROXYLATION OF DOXERCALCIFEROL, HENCE FORMATION OF ACTIVE MOITY MAY BE HINDERED
|
DAPOXETINE DOSE IS RESTRICTED TO 30 MG DUE TO POSSIBILITY OF INCREASED SIDE EFFECTS ON COADMINISTRATION
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
CO-ADMINISTRATION HAS RESULTED IN INHIBITION OF HEPATIC CYTOCHROME P450 BY CIMETIDINE PRODUCING SIGNIFICANT INCREASE IN PEAK DILTIAZEM PLASMA LEVELS AND AUC ; AN ADJUSTMENT IN DILTIAZEM DOSAGE MAY BE WARRENTED
|
DUE TO THE GASTRIC PH ELEVATING EFFECTS OF H2-BLOCKERS CONCOMITANT ADMINISTRATION OF EC-NAPROXEN IS NOT RECOMMENDED
|
H-2 RECEPTOR ANTAGONIST LIKE CIMETIDINE MAY DECREASE ITS ABSORPTION FROM THE GUT
|
H-2 RECEPTOR ANTAGONIST LIKE CIMETIDINE MAY DECREASE ITS ABSORPTION FROM THE GUT
|
H-2 RECEPTOR ANTAGONIST LIKE CIMETIDINE MAY DECREASE ITS ABSORPTION FROM THE GUT
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|